Analysed GALDERMA GROUP AG (GDERF:OTCMKTS) News Sources
Assessing Galderma Group (SWX:GALD) Valuation After Recent Share Price Resilience
26-03-2026
yahoo.com
EQT exits Galderma Group AG in full via largest sponsor-backed block trade ever
13-03-2026
yahoo.com
Galderma Buys Back Shares Worth CHF 232 Million in the Context of Accelerated Bookbuild Offering
11-03-2026
yahoo.com
Galderma Introduces Cetaphil AM/PM Antioxidant Serums, a New Science-Driven Defense and Recovery System for Sensitive Skin
09-03-2026
yahoo.com
Assessing Galderma Group (SWX:GALD) Valuation After Record 2025 Results And Upgraded Nemluvio Outlook
08-03-2026
yahoo.com
Galderma Group AG (GDERF) Full Year 2025 Earnings Call Highlights: Record Sales and Strategic ...
05-03-2026
yahoo.com
Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency1, and Core EBITDA2 of 1.211 billion USD, Growing 18.9% at Constant Currency
05-03-2026
yahoo.com
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics
25-02-2026
yahoo.com
What is the current price of GALDERMA GROUP AG (GDERF:OTCMKTS)?
The current price of GALDERMA GROUP AG (GDERF:OTCMKTS) is $175.61.
GALDERMA GROUP AG (GDERF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of GALDERMA GROUP AG (GDERF:OTCMKTS) since the previous trading day is $-29.04.
GALDERMA GROUP AG (GDERF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of GALDERMA GROUP AG (GDERF:OTCMKTS) since the previous trading day is -14.1901%.
What is the most recent average sentiment score for GALDERMA GROUP AG (GDERF:OTCMKTS)?
The most recent average sentiment score for GALDERMA GROUP AG (GDERF:OTCMKTS) is 81 out of 100.
What is the most recent average sentiment for GALDERMA GROUP AG (GDERF:OTCMKTS)?
The most recent sentiment for GALDERMA GROUP AG (GDERF:OTCMKTS) is .
SEC-8K** Filing Available For GALDERMA GROUP AG (GDERF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.